ASKA PHARMACEUTICAL CO., LTD.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Public, Subsidiary
- Established
- 1929-06-28
- Employees
- 501
- Market Cap
- -
- Website
- http://www.aska-pharma.co.jp
Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis
- First Posted Date
- 2019-04-30
- Last Posted Date
- 2020-12-11
- Lead Sponsor
- ASKA Pharmaceutical Co., Ltd.
- Target Recruit Count
- 335
- Registration Number
- NCT03931915
- Locations
- π―π΅
Rinkan Clinic, Kanagawa, Japan
π―π΅Shinsuma Hospital, Hyogo, Japan
π―π΅Tsujinaka Hospital Kashiwanoha, Chiba, Japan
Β© Copyright 2024. All Rights Reserved by MedPath